Although a more detailed in vivo study in stroke models with vitamin D is necessary, our in vitro results suggest to us that the neurovascular protective effects of 1,25(OH)2D3 treatment may prove an important adjunct strategy to improve the safety and efficacy of thrombolytic therapies such as tPA. This evidence concerns the gene PLAT and Stroke.